Matthew Brams
Founder at CINGULATE INC.
Net worth: 27 310 $ as of 30/04/2024
Profile
Matthew N.
Brams is the founder of Cingulate Works, Inc. (2013) and Cingulate, Inc. (2013), where he holds the title of Chief Medical Officer & Executive Vice President.
Currently, he is a Clinical Associate Professor at Baylor College of Medicine.
Previously, he worked as the Medical Director & Principal at Bayou City Research, Inc. (1999-2021).
He received his undergraduate degree from The University of Texas at Austin and his doctorate from the University of Texas Health Science Center at Houston.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CINGULATE, INC.
0.82% | 15/04/2024 | 32,512 ( 0.82% ) | 27 310 $ | 30/04/2024 |
Matthew Brams active positions
| Companies | Position | Start |
|---|---|---|
| CINGULATE INC. | Founder | 01/01/2013 |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Founder | - |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Founder | 01/01/2013 |
| Baylor College of Medicine | Corporate Officer/Principal | - |
Former positions of Matthew Brams
| Companies | Position | End |
|---|---|---|
| Bayou City Research, Inc. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Training of Matthew Brams
| The University of Texas at Austin | Undergraduate Degree |
| University of Texas Health Science Center at Houston | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Private companies | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Bayou City Research, Inc. |
- Stock Market
- Insiders
- Matthew Brams
